Lightcalls.com
 

In a 1985 issue of Scientific Ameri...

In a 1985 issue of Scientific American, in an article entitled "The Chemistry of Garlic and Onions," Eric stiffen Ph.D., wrote: "The world has always been divided into pair camps: those who love garlic and onions" and those who don't.

Among today's garlic researchers there are at least couple camps, as well, the garlic-extract persons and the powdered-garlic people:

The garlic-extract school-of-thought These scientists believe that aged garlic extract contains a variety of organosulfur mixs other than alliin/allicin, that are the principally important and medicinally beneficial garlic-based components

The powdered-garlic school-of-thought in succession the other hand, these scientists believe that alliin/allicin, and other sulfur pay by substitutions are the key ingredients not absent in powdered-garlic preparations, components which account for greatest in quantity of the beneficial effects associated with garlic and garlic supplements

Let's begin a dialogue in which we put to hire the research speak for itself:



Garlic-extract research.

Prostate cancer. In a subject of attention which appeared in a modern 1997 issue of the American Journal of Clinical Nutrition, of recent origin York City's Memorial Sloan-Kettering's John T Pinto, PhD and colleagues, gazeed at the effects of major water-soluble compromises derived from aged garlic extract (S-allylcysteine and S-allylmercaptocysteine) upon cultured (test-tube) human prostate cancer cells

The close attention found: 1) "Within 30 minutes of exposure" to either of the mixs proteins that are usually "hopp up" (present at heightened levels) as prostate tumors shoot up were suppressed; 2) intracellular horizontals of the reduced (antioxidant) form of glutathione were increased; and 3) a special enzyme (ornithine decarboxylase) which helps create those "bad-guy" proteins was blocked

Breast cancer. A series of studies on Pennsylvania State University's J.A. Milner, and colleagues (Carcinogenesis, 1992 & 1993 and Journal of Nutrition, 1996) reported that aged garlic extract significantly intercepted [blocked] breast cancer in as well-as; not only-but also; not only-but; not alone-but the beginning (initiation) and later (promotion) stages. The intermingle S-allylcysteine (SAC), by itself, also reduc the initiation of breast cancer.

Bladder cancer. In a newly come experimental study by Donald L Lamm, MD and colleagues (Cancer, May 15 1997) at West Virginia University, mice with bladder cancer were given either aged garlic extract or a salt-water placebo solution. The proceeds were positive, leading the authors to conclude: "the significant antitumor [effectiveness] of [aged garlic extract] warrants further investigation and intimates that [this compound] may provide a novel and effective form of therapy for transitional solitary abode; squalid carcinoma of the bladder."

Other cancer studies. Including the above three studies, there are a total of 49 studies (since 1983) pointing to the anti-cancer consequences of aged garlic extract and its constituents. Among these are 17 breast cancer studies, seven forward colon cancer, and five in succession bladder cancer.

Powdered-garlic research.

Anti-cancer be the effects have also been suggested, as early as 1957 in a report in Science according to Austin Weisberger and Jack Pensky which indicated that "[a pay with an abatement similar to allicin] may have tumor-inhibiting weights when malignant cells are placed directly in contact with this pay with an abatement prior to inoculation."

abundant more recently, a 1991 thought by Michael J. Wargovich currented at the Second International Garlic Symposium direct the eyeed at organosulphur compounds derived from garlic, of the like kind as diallyisulfide (DAS) and S-allylcysteine (SAC) [also institute by Pinto in aged garlic extract] and gastrointesinal cancer -- colorectal and esophageal.

In this rat close attention both compounds successfully prevented colorectal cancer, and DAS specifically "protect rats from developing esophageal cancer." Wargovich conclud that these mixs seem to block cancer at the early initiation stage.

Stomach/urinary cancer. In 1997 K Polasa and K Krishnaswamy published a powdered-garlic consideration in Cancer Letters, in which rats expos to urinary cancer-causing chemicals (mutagens) were given comminuteed garlic.

The comes were positive, with the authors reporting that "`there was a significant reduction in the excretion of [cancer-causing agents, suggesting a cancer-protective effect] at carcinogen-exposed rats fed [powdered] garlic."

Population-based garlic research. Several population-based studies forward people in China, Italy, Iowa, and California have shown that adding garlic to the daily diet can shorten the risk of certain emblems of cancer, such as stomach and colon cancer.

thus there is the briefest of samples as to the studies that are gone out there, and thus begins our dialogue forward research that's on the "frontiers of science."

COPYRIGHT 1998 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved

COPYRIGHT 2000 Gale Group



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.